CPC
CBST

Cookson Peirce & Co’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Cookson Peirce & Co’s Portfolio CBST Stock Details CBST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-14,770
Closed -$1.08M – 180
2014
Q1 		$1.08M Buy
14,770
+1,030
+7% +$76.8K 0.27% 78
2013
Q4 		$946K Buy
+13,740
New +$889K 0.25% 80

Other funds holding CBST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Cookson Peirce & Co's CBST Position: Q2 2014 in Review

Cookson Peirce & Co sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q2 2014, closing a stake of 14,770 shares — an estimated $1.08M sold.

Cookson Peirce & Co first reported a position in CBST in Q4 2013 and held it in 2 quarters. The position peaked at $1.08M in Q1 2014. 270 funds tracked by Wall St. Rank hold CBST as of Q2 2014.

  • Cookson Peirce & Co reported no remaining CUBIST PHARMACEUTICALS INC position as of Q2 2014 after selling out during the quarter.
  • Cookson Peirce & Co sold 14,770 CUBIST PHARMACEUTICALS INC shares in Q2 2014, an estimated $1.08M.
  • Cookson Peirce & Co first reported a position in CUBIST PHARMACEUTICALS INC in Q4 2013 and held it in 2 quarters.
  • Cookson Peirce & Co's CUBIST PHARMACEUTICALS INC position peaked at $1.08M in Q1 2014.
  • 270 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q2 2014.

Based on Cookson Peirce & Co's 13F filing for Q2 2014, filed 14 Aug 2014.